Acrivon Therapeutics (ACRV) Cash & Current Investments (2021 - 2026)
Acrivon Therapeutics (ACRV) reported Cash & Current Investments of $89.96 million for Q2 2026, down 34.5% from $137.42 million a year earlier and down 8.0% from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Cash & Current Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Acrivon Therapeutics posted Cash & Current Investments of $118.58 million, down 33.9% from FY2024.
- Cash & Current Investments has a four-year compound annual growth rate of 4.5% (FY2021 to FY2025).
- By year, Cash & Current Investments came in at $179.48 million in FY2024 (+40.8%), $127.46 million in FY2023 (-0.2%), $127.75 million in FY2022 (+28.3%) and $99.6 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Cash & Current Investments since Q3 2022.
- Year over year, Cash & Current Investments has now declined in each of the last five quarters, with an average decline of 6.2% over the last eight quarters.
- The high point for year-over-year Cash & Current Investments in five years was Q3 2023 (growth of 85.0%); the low point was Q1 2026 (a decline of 34.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $97.74 million (Q1 2026), $118.58 million (Q4 2025) and $129.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Acrivon Therapeutics | 70.71 Mn | -364.82 Mn | - | 89.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 89.96 Mn |
| Mar 31, 2026 | 97.74 Mn |
| Dec 31, 2025 | 118.58 Mn |
| Sep 30, 2025 | 129.25 Mn |
| Jun 30, 2025 | 137.42 Mn |
| Mar 31, 2025 | 149.64 Mn |
| Dec 31, 2024 | 179.48 Mn |
| Sep 30, 2024 | 187.45 Mn |
| Jun 30, 2024 | 180.54 Mn |
| Mar 31, 2024 | 109.98 Mn |
| Dec 31, 2023 | 127.46 Mn |
| Sep 30, 2023 | 142.09 Mn |
| Jun 30, 2023 | 150.95 Mn |
| Mar 31, 2023 | 120.21 Mn |
| Dec 31, 2022 | 127.75 Mn |
| Sep 30, 2022 | 76.82 Mn |
| Jun 30, 2022 | 83.86 Mn |
| Mar 31, 2022 | 90.77 Mn |
| Dec 31, 2021 | 99.60 Mn |
| Sep 30, 2021 | 3.61 Mn |
API Access
Acrivon Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();